Rasmus Holm-Jorgensen

Insider Reports History

Location
C/O Acrivon Therapeutics, Inc., 480 Arsenal Way, Suite 100, Watertown, MA
Signature
/s/ Rasmus Holm-Jorgensen
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Rasmus Holm-Jorgensen:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Acrivon Therapeutics, Inc. Chief Financial Officer Common Stock 26.1K $141K $5.42 Feb 14, 2025 Direct
Acrivon Therapeutics, Inc. Chief Financial Officer Stock Option (Right to Buy) 109K Mar 1, 2025 Direct

Insider Reports Filed by Rasmus Holm-Jorgensen

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ACRV Acrivon Therapeutics, Inc. Mar 1, 2025 1 $0 4 Mar 4, 2025 Chief Financial Officer
ACRV Acrivon Therapeutics, Inc. Feb 14, 2025 1 -$2.35K 4 Feb 19, 2025 Chief Financial Officer
ACRV Acrivon Therapeutics, Inc. Nov 14, 2024 1 -$2.91K 4 Nov 18, 2024 Chief Financial Officer
ACRV Acrivon Therapeutics, Inc. Aug 14, 2024 1 -$2.58K 4 Aug 16, 2024 Chief Financial Officer
ACRV Acrivon Therapeutics, Inc. May 14, 2024 1 -$3.08K 4 May 16, 2024 Chief Financial Officer
ACRV Acrivon Therapeutics, Inc. Mar 1, 2024 1 $0 4 Nov 27, 2024 Chief Financial Officer
ACRV Acrivon Therapeutics, Inc. Feb 14, 2024 1 -$1.48K 4 Feb 16, 2024 Chief Financial Officer
ACRV Acrivon Therapeutics, Inc. Nov 14, 2023 1 -$7.47K 4 Nov 16, 2023 Chief Financial Officer
ACRV Acrivon Therapeutics, Inc. Jun 16, 2023 2 $34.5K 4 Jun 20, 2023 Chief Financial Officer
ACRV Acrivon Therapeutics, Inc. Nov 14, 2022 2 $0 4 Nov 16, 2022 Chief Financial Officer
ACRV Acrivon Therapeutics, Inc. Nov 9, 2022 0 $0 3 Nov 9, 2022 Chief Financial Officer